Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|March 8, 2020
Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related OutcomesHabiba Kamal, Gabriel Westman, Karolin Falconer, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Infectious Diseases (London, England)|September 25, 2024
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in SwedenIsabela Killander Möller, Pontus Hedberg, Philippe Wagner, et al.
Journal of Hepatology|May 16, 2026
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flaresHeiner Wedemeyer, Ed Gane, Kosh Agarwal, et al.
EMBO Molecular Medicine|August 20, 2022
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cellsSofia Appelberg, Gustaf Ahlén, Jingyi Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Haematologica|August 30, 2023
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemiaHanna M Ingelman-Sundberg, Lisa Blixt, David Wullimann, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|March 8, 2020
Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related OutcomesHabiba Kamal, Gabriel Westman, Karolin Falconer, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Infectious Diseases (London, England)|September 25, 2024
Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in SwedenIsabela Killander Möller, Pontus Hedberg, Philippe Wagner, et al.
Journal of Hepatology|May 16, 2026
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flaresHeiner Wedemeyer, Ed Gane, Kosh Agarwal, et al.
EMBO Molecular Medicine|August 20, 2022
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cellsSofia Appelberg, Gustaf Ahlén, Jingyi Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.
Haematologica|August 30, 2023
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemiaHanna M Ingelman-Sundberg, Lisa Blixt, David Wullimann, et al.
Pageof 15